Potential neurochemical links between cholesterol and suicidal behavior

被引:35
作者
Cantarelli, Maria da Graca [1 ]
Tramontina, Ana Carolina [2 ]
Leite, Marina C. [3 ]
Goncalves, Carlos-Alberto [1 ,3 ]
机构
[1] Univ Fed Rio Grande do Sul, Neurosci Postgrad Program, BR-90035003 Porto Alegre, RS, Brazil
[2] State Univ Rio Grande do Sul UERGS, Rio De Janeiro, Brazil
[3] Univ Fed Rio Grande do Sul, Dept Biochem, BR-90035003 Porto Alegre, RS, Brazil
关键词
Astrocyte; BDNF; Cholesterol; Lipid rafts; Serotonin; Suicidal behavior; S100B protein; LOW SERUM-CHOLESTEROL; CORONARY-HEART-DISEASE; LIPID RAFTS; PRIMARY PREVENTION; MAJOR DEPRESSION; FATTY-ACIDS; ASSOCIATION; MORTALITY; SEROTONIN; METABOLISM;
D O I
10.1016/j.psychres.2014.10.017
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The role of cholesterol in psychiatric diseases has aroused the interest of the medical community, particularly in association with violent and suicidal behavior. Herein, we discuss some aspects of brain cholesterol metabolism, exploring possible mechanisms underlying the findings and reviewing the available literature on the possible neurochemical link between suicide and low or reduced levels of serum cholesterol. Most of the current hypotheses suggest a decreased serotonergic activity due to a decrease in cholesterol in the lipid rafts of synaptic membranes. Some aspects and limitations of this assumption are emphasized. In addition to serotonin hypofunction, other mechanisms have been proposed to explain increased impulsivity in suicidal individuals, including steroid modulation and brain-derived neurotrophic factor decrease, which could also be related to changes in lipid rafts. Other putative markers of suicidal behavior (e.g. protein S100B) are discussed in connection with cholesterol metabolism in the brain tissue. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:745 / 751
页数:7
相关论文
共 116 条
  • [31] Lipids and essential fatty acids in patients presenting with self-harm
    Garland, Malcolm R.
    Hallahan, Brian
    McNamara, Mairead
    Carney, Philip A.
    Grimes, Helen
    Hibbeln, Joseph R.
    Harkin, Andrew
    Conroy, Ronan M.
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2007, 190 : 112 - 117
  • [32] ABCG1 gene variants in suicidal behavior and aggression-related traits
    Gietl, Anton
    Giegling, Ina
    Hartmann, Annette M.
    Schneider, Barbara
    Schnabel, Axel
    Maurer, Konrad
    Moeller, Hans-Juergen
    Rujescu, Dan
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 (6-7) : 410 - 416
  • [33] Goncalves C.A., 2010, CARDIOVASC PSYCHIAT, V2010
  • [34] Biological and methodological features of the measurement of S100B, a putative marker of brain injury
    Goncalves, Carlos-Alberto
    Leite, Marina Conch
    Nardin, Patricia
    [J]. CLINICAL BIOCHEMISTRY, 2008, 41 (10-11) : 755 - 763
  • [35] Relationship between attempted suicide, serum cholesterol level and novelty seeking in psychiatric in-patients
    Guillem, E
    Pélissolo, A
    Notides, C
    Lépine, JP
    [J]. PSYCHIATRY RESEARCH, 2002, 112 (01) : 83 - 88
  • [36] Systematic Review on Evidence of the Effectiveness of Cholesterol-Lowering Drugs
    Gupta, Abhaya
    Guyomard, Veronique
    Zaman, M. Justin S.
    Rehman, Habib U.
    Myint, Phyo Kyaw
    [J]. ADVANCES IN THERAPY, 2010, 27 (06) : 348 - 364
  • [37] Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms
    Harrison, AA
    Everitt, BJ
    Robbins, TW
    [J]. PSYCHOPHARMACOLOGY, 1997, 133 (04) : 329 - 342
  • [38] Self-harm and suicide in adolescents
    Hawton, Keith
    Saunders, Kate E. A.
    O'Connor, Rory C.
    [J]. LANCET, 2012, 379 (9834) : 2373 - 2382
  • [39] Lipid Metabolism and Glial Lipoproteins in the Central Nervous System
    Hayashi, Hideki
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (04) : 453 - 461
  • [40] Risks of cholesterol-lowering therapies
    Hibbeln, JR
    Salem, N
    [J]. BIOLOGICAL PSYCHIATRY, 1996, 40 (07) : 686 - 687